Migraine Treatment With Nerivio Migra Neurostimulation Device
Stopped early · Not applicable · Has a placebo group
Conditions studied: Acute Migraine
In brief
This is a prospective, randomized, double-blind, sham controlled multi-center trial. Ratio between treatment and control groups will be 1:1, stratified by center and use of preventive medications.
Key facts
- Study ID
- NCT03076515
- Run by
- Theranica
- People needed
- 120
- Starts
- 2017-04-02
- Expected to finish
- 2018-04-01
- Last updated by the study team
- 2025-07-17
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient is 18-75 years old.
- Patient meeting the ICHD-3 diagnostic criteria for migraine with and without aura.
- Patients reporting 2-8 migraine attacks per month.
- Patient must be able and willing to comply with the protocol.
- Patient must be able and willing to provide written informed consent.
- Male or non-pregnant / non-lactating female (NOTE: Females of child bearing potential must have a negative pregnancy test) and must be willing to use adequate contraceptive means during the study
You may not qualify if…
- Has other significant pain problem that in the opinion of the investigator may confound the study assessments
- Is currently implanted with an electrical and/or neurostimulator device (e.g. cardiac pacemaker or defibrillator, vagus nerve neurostimulator, deep brain stimulator, spinal stimulator, bone growth stimulator cochlear implant, Sphenopalatine ganglion stimulator or Occipital nerve stimulator).
- Known uncontrolled epilepsy.
- Use of Cannabis including medical use.
- Has chronic migraine (more than 15 headache days per month).
- Changed usage or dosage of migraine preventive medications in the last two months
- Has undergone nerve block (occipital or other) in the head or neck within the last 2 weeks.
- Is participating in any other clinical study. -
Where it is running
- MedStar - Georgetown University Hospital — Washington D.C., District of Columbia, United States
- Albany Medical College — Albany, New York, United States
- Hartford Healthcare Headache Center — Hartford, New York, United States
- Northwell Health, Inc — New York, New York, United States
- Hillel Yaffe Medical Center — Hadera, Israel
- Herzeliya medical Center — Herzliya, Israel
- Maccabi Healthcare neurology clinics — Kfar Saba, Israel
- Western Galilee Medical Center — Nahariya, Israel
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.